{"id":"a-hydrogel-containing-erythropoietin","phase":"phase_1","safety":{"commonSideEffects":[{"rate":"2.3%","effect":"Thromboembolism"},{"rate":"1.8%","effect":"Hypertension"},{"rate":"1.5%","effect":"Headache"}]},"status":"active","trials":["NCT02361931"],"aliases":["Standard of care (SOC)"],"patents":[],"pricing":[],"timeline":[],"aiSummary":"Stimulates erythropoiesis by binding to and activating the erythropoietin receptor Used for Anemia associated with chronic kidney disease, Anemia associated with cancer chemotherapy.","brandName":"A hydrogel containing erythropoietin","companyId":"remedor-biomed-ltd","mechanism":{"_ai_source":"groq-llama-8b","explanation":"Erythropoietin binds to its receptor on the surface of erythroid progenitor cells, triggering a signaling cascade that promotes the proliferation and differentiation of these cells into mature red blood cells.","oneSentence":"Stimulates erythropoiesis by binding to and activating the erythropoietin receptor","_ai_confidence":"high"},"commercial":null,"companyName":"Remedor Biomed Ltd","competitors":[],"genericName":"A hydrogel containing erythropoietin","indications":{"approved":[{"name":"Anemia associated with chronic kidney disease"},{"name":"Anemia associated with cancer chemotherapy"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":17,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}